Contingent Liabilities and Commitments

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies Disclosure [Text Block]

NOTE 12 : Contingent Liabilities and Commitments

Litigation

The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At December 31, 2015 and 2014, there were no contingent liabilities with respect to any threat of litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company’s consolidated financial position, results of operations, cash flows or liquidity.

Material Commitments

The Company has commitments to purchase services from Recipharm Pessac for a total of $22,500 for a five-year period commencing January 1, 2015 (disclosed in Note 17- Discontinued Operations) and to purchase one batch per year for the next five years of the generic pharmaceutical product it markets for $46 per year.

The Company and its subsidiaries lease office facilities under noncancelable operating leases expiring at various dates. Rent expense was $752, $844 and $759 in 2015, 2014, and 2013, respectively. Minimum rental commitments for non-cancelable leases in effect at December 31, 2015 are as follows:

2016	$	784
2017		472
2018		463
2019		389
2020		310
Thereafter		-
Total	$	2,418

Other than the above commitments to Recipharm and for operating leases, there were no other material commitments outside of the normal course of business. Material commitments in the normal course of business include long-term debt, long-term contingent consideration payable, and post-retirement benefit plan obligations which are disclosed in Note 7 - Long-Term Debt , Note 8 – Long-term Contingent Consideration Payable, and Note 10 – Post-Retirement Benefit Plans, respectively.